Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tyler White

Orthopaedic Surgery of the Spine Grand Island, NE Medical Doctor

NPI 1922460518 CMS profile 4220462

620 N Diers Ave Ste 200, Grand Island, NE 68803

Open in the dashboard

General payments

$7,475

87 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tyler White of Grand Island, NE is reported in the CMS Open Payments database as having received $7,475 across 87 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 41st percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $390 19
2024 General $261 11
2023 General $265 11
2022 General $1,108 24
2021 General $1,519 17
2020 General $49 1
2019 General $3,885 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tyler White
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Tyler White were reported at $390. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Tyler White Orthopaedic Surgery of the Spine median Middle half National median
2019 $3,885 $2,106 $337–$18,608 $163
2020 $49 $1,213 $156–$15,082 $114
2021 $1,519 $1,834 $271–$15,617 $132
2022 $1,108 $2,015 $320–$17,036 $149
2023 $265 $1,925 $336–$14,599 $160
2024 $261 $2,110 $341–$12,483 $164
2025 $390 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alon Medical Technology $3,996 6 payments
  2. Medtronic, Inc. $1,138 18 payments
  3. Stryker Corporation $1,090 18 payments
  4. DePuy Synthes Sales Inc. $309 9 payments
  5. Orthofix Medical, Inc. $162 7 payments
  6. Pacira Pharmaceuticals Incorporated $149 3 payments
  7. SI-BONE, Inc. $117 3 payments
  8. Conetic Solutions, Inc. $84 5 payments
  9. Smith+Nephew, Inc. $80 3 payments
  10. Cerapedics, Inc. $75 1 payment
  11. Other $274 14 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $4,358 6 payments
  2. Food and Beverage $3,117 81 payments
Products named General payments · program years 2019–2025
  1. Mazor X Stealth Edition $487 3 payments
  2. PRIME SERIES $372 5 payments
  3. EXPEDIUM $212 4 payments
  4. Xvision $182 5 payments
  5. ENDOSKELETON TL NANOLOCK SURFACE TECHNOLOGY $173 1 payment
  6. Exparel $149 3 payments
  7. MAZOR X SYSTEM $117 3 payments
  8. GAMMA $110 2 payments
  9. CD HORIZON $93 2 payments
  10. M6-C $91 1 payment
  11. Other $1,317 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

157

Median for Orthopedic Surgery: 203

Drug cost

$673

Median for Orthopedic Surgery: $1,433

Branded share of claims

7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methylprednisolone Generic 29 $197
Oxycodone Hcl Generic 32 $125
Cyclobenzaprine Hcl Generic 25 $115
Tramadol Hcl Generic 34 $90
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $58
Gabapentin Generic 13 $53
Meloxicam Generic 13 $37

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 92 billing codes

Paid by Medicare

$238,195

Medicare's payments for the services billed

Medicare patients

389

Average age 75

Services billed

1,877

230 women, 159 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 29%
Ischemic heart disease 27%
Osteoporosis 25%
Depression 24%
Chronic kidney disease 20%
COPD 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

87 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Nebraska

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record